Novartis will start with 30 to 35 accredited sites, while Santa Monica-based Kite plans to have 10 locations at first.
Kite Chief Commercial Officer Shawn Tomasello said the uniqueness of CAR-T requires caution.
“Typically with the launch of a new product, I would be in a ‘fast and furious, immediate revenue up and to the right as fast as you can’ mode,” she said. “This is not the place to employ that strategy.”
This article was provided by Bloomberg News.